Ling-Di Li
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 22
- Acute Myeloid Leukemia Research 15
- Multiple Myeloma Research and Treatments 6
- Chronic Myeloid Leukemia Treatments 5
-
- Retinoids in leukemia and cellular processes 4
- Co-authors
- Xiao‐Jun Huang (26 shared papers)Jinlan Li (22 shared papers)Ya‐Zhen Qin (13 shared papers)Guo‐Rui Ruan (16 shared papers)Bin Jiang (9 shared papers)Dang Wu (1 shared paper)Qun Yu (1 shared paper)Lijun Li (2 shared papers)
- Journals
- Leukemia Research (5 papers)Scientific Reports (3 papers)Biochemical and Biophysical Research Communications (1 paper)Environmental Toxicology (1 paper)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Ling-Di Li
50 papers receiving 435 citations
Peers
Comparison fields: 5 of 69
- Hematology 197
- Genetics 78
- Cancer Research 39
- Molecular Biology 188
- Oncology 57
Countries citing papers authored by Ling-Di Li
This map shows the geographic impact of Ling-Di Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling-Di Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling-Di Li more than expected).
Fields of papers citing papers by Ling-Di Li
This network shows the impact of papers produced by Ling-Di Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling-Di Li. The network helps show where Ling-Di Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling-Di Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 65 | |
| 2 | 2008 | 49 | |
| 3 | 2013 | 29 | |
| 4 | 2013 | 24 | |
| 5 | 2012 | 22 | |
| 6 | 2010 | 22 | |
| 7 | 2017 | 19 | |
| 8 | 2016 | 17 | |
| 9 | Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation. | 2011 | 16 |
| 10 | 2015 | 15 | |
| 11 | 2016 | 15 | |
| 12 | 2014 | 12 | |
| 13 | Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation. | 2012 | 9 |
| 14 | 2015 | 9 | |
| 15 | 2014 | 8 | |
| 16 | 2021 | 7 | |
| 17 | [Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique]. | 2007 | 7 |
| 18 | 2020 | 6 | |
| 19 | [Adenovirus-mediated PDCD5 gene transfer sensitizes apoptosis of K562 cells induced by etoposide]. | 2007 | 6 |
| 20 | 2023 | 5 |
About Ling-Di Li
Ling-Di Li is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Cancer Research, having authored 52 papers that have together received 441 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers), Multiple Myeloma Research and Treatments (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Retinoids in leukemia and cellular processes (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Immunotherapy and Immune Responses (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Hematology (197 citations), Genetics (78 citations), Cancer Research (39 citations), Molecular Biology (188 citations) and Oncology (57 citations). Ling-Di Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiao‐Jun Huang, Jinlan Li, Ya‐Zhen Qin, Guo‐Rui Ruan, Bin Jiang, Dang Wu, Qun Yu, Lijun Li, Pin Wu and Yanrong Liu. Their work appears in journals such as Leukemia Research, Scientific Reports, Biochemical and Biophysical Research Communications, Environmental Toxicology and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.